ENTITY
Cargo Therapeutics

Cargo Therapeutics (CRGX US)

1
Analysis
Health CareUnited States
Cargo Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing chimeric antigen receptor (CAR) T-cell therapies for the treatment of cancer patients. Cargo Therapeutics serves customers in the United States.
more
Event Icon
No events found
We’ll display events we find for Cargo Therapeutics here
x